Sun Pharma Global FZE v. Lupin Ltd.
- Docket:
- 18-2213
Case noted for disambiguation because it involved U.S. 8,778,999, a bromfenac/Bromsite patent different from 6,030,999.
8778999
3 known cases. View patent page →
- Cases
- 3
- Active
- 1
- 2 closed
- Filed
- 2018–2026
- Top venue
- D. New Jersey
- 3 cases
Sun Pharmaceutical Industries Ltd. et al. v. Lupin Ltd. et al.
settled and dismissed with prejudice- Docket:
- 3:18-cv-02213
- Filed:
- 2018-02-15
Patents:8778999
π Sun Pharmaceutical Industries Ltd.π Sun Pharmaceutical Industries, Inc.π Sun Pharma Global FZEΔ Lupin Ltd.Δ Lupin Pharmaceuticals, Inc.
Hatch-Waxman ANDA infringement action by Sun against Lupin concerning Lupin's ANDA No. 211239 for bromfenac ophthalmic solution 0.075%. The court found the ’999 patent not literally infringed, obvious, and indefinite, but the case was settled and dismissed with prejudice in February 2022, with the September 30, 2021 opinion vacated.
Sun Pharmaceutical Industries Ltd. et al. v. Solaris Pharma Corporation
pending- Docket:
- 2:26-cv-04286
- Filed:
- 2026-04-22
π Sun Pharmaceutical Industries Ltd.π Sun Pharmaceutical Industries, Inc.Δ Solaris Pharma Corporation
Hatch-Waxman/DJ action filed by Sun against Solaris concerning Solaris's ANDA No. 220440 for bromfenac ophthalmic solution 0.075%, asserting U.S. Patent RE50,218, the reissue of the ’999 family, rather than the ’999 patent itself. The case was pending/just filed.